To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 29 June 2021 to Question 21839 on Coronavirus: Ivermectin, what further assessment he has made of the efficacy of the use of Ivermectin as a treatment for covid-19.
22 November 2021
The Department continues to monitor any new evidence for ivermectin as a treatment for COVID-19. While we are aware that although some clinical trials have shown positive signals for the potential efficacy of ivermectin, there are no supportive randomised control trials and insufficient evidence to support use for COVID-19. Results from the PRINCIPLE clinical trial platform, launched in June, are expected in early 2022 and we will monitor data from worldwide clinical trials on the efficacy of ivermectin.